SCHEMBL6644168

SCHEMBL6644168

C=C(c1ccccc1)c1cccc(C(=NOCc2ccc(OCc3nc(-c4ccccc4)oc3C)cc2)C(=O)O)c1

nearest known ligand 0.65

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PPARG P37231 13/20 0.65
PPARA Q07869 11/20 0.65
FFAR1 O14842 1/20 0.55
KDR P35968 1/20 0.50
MAPT P10636 3/20 0.47
PPARD Q03181 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6644166 1.00 PPARG (0.65) PPARGPPARAFFAR1KDRMAPT
SCHEMBL6156874 0.92 PPARG (0.62) PPARGPPARAFFAR1KDRMAPT
SCHEMBL6156870 0.92 PPARG (0.62) PPARGPPARAFFAR1KDRMAPT
SCHEMBL6157943 0.92 PPARG (0.67) PPARGPPARAFFAR1KDRMAPT
SCHEMBL6157946 0.92 PPARG (0.67) PPARGPPARAFFAR1KDRMAPT
SCHEMBL6157446 0.92 PPARG (0.59) PPARGPPARAFFAR1KDRMAPT
SCHEMBL6158357 0.90 PPARG (0.75) PPARGPPARAFFAR1KDRMAPT
SCHEMBL4054572 0.90 PPARG (0.75) PPARGPPARAFFAR1KDRMAPT
SCHEMBL4054575 0.90 PPARG (0.75) PPARGPPARAFFAR1KDRMAPT
SCHEMBL6157716 0.89 PPARG (0.66) PPARGPPARAFFAR1KDRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1077957-B1 OXYIMINOALKANOIC ACID DERIVATIVES WITH HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIVITY TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2004-08-04 EP disclosed
EP-1428531-A1 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-06-16 EP disclosed
US-6495581-B1 DRUG FOR TREATING DIABETES MELLITUS, HYPERLIPEMIA, IMPAIRED GLUCOSE TOLERANCE, ARTERIAL SCLEROSIS AND IMPROVING INSULIN RESISTANCE, INFLAMMATORY DISEASE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-12-17 US disclosed
US-6251926-B1 OXYIMINOALKANOIC ACID DERIVATIVES HAVING HYPOGLYCEMIC EFFECT AND HYPOLIPIDEMIC EFFECT, IS USEFUL FOR TREATMENT OF DIABETES MELLITUS, HYPERLIPEMIA, IMPAIRED GLUCOSE TOLERANCE INFLAMMATORY DISEASE AND ARTERIOSCLEROSIS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-06-26 US disclosed
EP-1077957-A1 OXYIMINOALKANOIC ACID DERIVATIVES WITH HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIVITY Takeda Chemical Industries, Ltd. (JP) 2001-02-28 EP disclosed
WO-1999058510-A1 OXYIMINOALKANOIC ACID DERIVATIVES WITH HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIVITY TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-11-18 WO disclosed